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ABSTRACT: Background. The role of minimally invasive surgery in
Graves’ disease is still controversial. The aim of this study was to
compare the clinical outcomes of patients undergoing minimal-incision
thyroidectomy with those undergoing conventional thyroidectomy for
Graves’ disease.
Methods. A prospective study was performed on 148 patients
undergoing total thyroidectomy. Seventy-one patients underwent
minimal-incision thyroidectomy and 77 underwent conventional
thyroidectomy. Minimal-incision thyroidectomy was proposed if the
thyroid volume was 50 mL.
Results. There were no significant differences in the operative time between
minimal-incision thyroidectomy and conventional thyroidectomy. The length of
skin incision was significantly shorter in the minimal-incision thyroidectomy
than that in the conventional thyroidectomy group. The incidence of
postoperative complications was similar in the 2 groups. Patients undergoing
minimal-incision thyroidectomy experienced significantly less postoperative
pain and were more satisfied with the cosmetic result than patients who
underwent conventional thyroidectomy.
Conclusions. Minimal-incision thyroidectomy is a feasible and safe
option for the surgical treatment of selected patients with Graves’
disease.VC 2012 Wiley Periodicals, Inc. Head Neck 00: 000–000, 2012
KEY WORDS: thyroid, Graves’ disease, minimally invasive surgery,
minimal-incision thyroidectomy, postoperative complications
INTRODUCTION
Current treatment of Graves’ disease is based on
antithyroid drugs, radioactive iodine, and surgery. Medi-
cal management is generally the first choice, whereas
surgery is recommended to patients who either refuse
radioactive iodine or experience disease recurrence after
previous drug or iodine treatment. Large glandular vol-
ume, suspect of malignancy, young age, severe ophthalm-
opathy, and pregnancy are the other main indications for
surgery.1,2
Total thyroidectomy is considered the standard surgical
procedure for Graves’ disease by several authors.3–6 The
advantages of a radical operation as compared with less
than total thyroidectomy may be the following: (1) no
risk of disease recurrence and, thus, no risk of increased
morbidity associated with secondary operation; (2) better
control of immunological disorder with possible benefi-
cial effect on ophthalmopathy; (3) adequate treatment of
incidental thyroid malignancy; and (4) easier L-tiroxine
substitution in the athyroid patient. Importantly, it has
been shown that the morbidity and cosmetic impact of
cervical incision after total thyroidectomy are comparable
to those of subtotal thyroidectomy.7–9
Recently, minimally invasive surgery has been success-
fully used for the treatment of both benign and malignant
thyroid disorders. The well-known advantages of this
approach are the reduced postoperative pain, improved
cosmesis (patients are usually young females), shorter
hospital stay, and lower costs.10–16 However, the role of
minimally invasive surgery techniques in the treatment of
Graves’ disease is still uncertain. This is mainly due to
increased glandular vascularity and frequent periglandular
inflammation, resulting in potential technical difficulties
and an increased incidence of complications.17
The aim of this study was to compare the efficacy and
safety of open, nonendoscopic minimal-incision thyroid-
ectomy with that of conventional thyroidectomy in the
treatment of patients with Graves’ disease.
MATERIALS AND METHODS
Patients
Between October 2002 and December 2009, 189 con-
secutive patients with a confirmed diagnosis of Graves’
disease underwent total thyroidectomy by the same sur-
geon at the Endocrine and Minimally Invasive Surgery
Unit of the University of Florence, Italy. In all, 148 of
these 189 patients were enrolled in this prospective,
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nonrandomized study: 71 patients (64 female, 7 male;
mean age, 41.4 6 1.4 years) underwent minimal-incision
thyroidectomy, whereas the remaining 77 patients (56
female and 21 male; mean age, 46.4 6 1.3 years) under-
went conventional thyroidectomy and formed a control
group. Patients were selected for minimal-incision thy-
roidectomy if the thyroid volume was 50 mL measured
by means of ultrasonography. All patients were treated
with an antithyroid drug and/or b-blockers before surgery
until stable clinical and serologically proven euthyroidism
was achieved. All patients had been thoroughly informed
about the study and gave written consent for the investi-
gation in accord with the ethical guidelines of our
university.
The indications for surgery are shown in Table 1.
Surgical technique
Minimal-incision thyroidectomy is an open, nonendo-
scopic procedure and was performed in accord with the
methods previously described.18 Briefly, a 2.5- to 3.5-cm
incision in a central skin crease of the neck is made
approximately 3 cm above the sternal notch. A minimal
subplatysmal flap is made and the cervical linea alba is
divided longitudinally for at least 3 cm. Strap muscles of
the affected side are retracted with small conventional
retractors. Blunt dissection of the lateral aspect of the
thyroid, including division of the middle thyroid vein, di-
vision of the superior thyroid artery and vein, and identi-
fication of the recurrent laryngeal nerves and parathyroid
glands are performed with the aid of an additional head
light source and the use of traditional tiny surgical instru-
ments. Vessels are divided between conventional liga-
tures. Wound closure includes platysma and skin with
reabsorbable sutures.
Conventional thyroidectomy is performed through a
4.5- to 8-cm transverse cervical incision. Subplatysmal
flaps are extended to the level of the hyoid bone and
inferiorly to the sternal notch. After separating and later-
ally retracting the strap muscles, the gland is removed in
a fashion similar to that reported for minimal-incision
thyroidectomy. Drains were placed in both groups.
Preoperative and postoperative (6 and 18 hours after the
operation) serum calcium levels (normal range, 8.2–10.7
mg/dL) were assessed in all patients. Hypocalcemia was
distinguished as asymptomatic or symptomatic. On the
first postoperative day, laryngoscopy was performed to
check vocal cord motility in all patients. Generally,
patients were discharged on the first postoperative day
with oral levothyroxine substitution therapy. Oral calcium
and vitamin D supplementation were administered only
when hypocalcemia developed.
Operative outcomes, postoperative complications, and
final pathologic report were recorded. Postoperative pain
was assessed by means of a visual analogue scale (VAS).
This scale consisted of a 10-cm line with the words no
pain on the left side, at zero, and worst pain imaginable
on the right side, at 10. All patients were asked to evalu-
ate their pain 6 and 18 hours after the operation by indi-
cating its level on the line. Cosmetic results were eval-
uated with a numerical score system (NSS) ranging from
0 to 10. The patients were asked to grade the cosmetic
appearance of their wound 1 month after surgery.
Statistical analysis
Categorical variables within the minimal-incision thy-
roidectomy and conventional thyroidectomy groups were
compared using Fisher’s exact test or the chi-square test.
Quantitative variables were summarized by mean 6
SEM. Differences in these parameters between the 2
study groups were compared using the Mann–Whitney
test. Statistical analysis was performed using Stata Statis-
tical Software (release 5.0; Stata Corporation, College
Station, TX). Probability was determined using 2-sided
statistical tests, with p < .05 considered statistically
significant.
RESULTS
Patients underwent surgery after an average of 2.3 6
1.2 and 2.8 6 1.5 months of preoperative medical prepa-
ration in the minimal-incision thyroidectomy and in the
conventional thyroidectomy group, respectively (p ¼ not
significant [NS]).
Table 2 summarizes the main operative outcomes in
the 2 groups. There were no significant differences in the
operative time between the 2 procedures. No patient in
the minimal-incision thyroidectomy group required con-
version to conventional thyroidectomy. In only 3 patients
was the initial skin incision extended for another 10 mm
to allow the extraction of glands of critical volume. In
these cases we used the final length for statistical
TABLE 1. Indications for surgery.
No of patients (%)
Factor MIT (n ¼ 71) CT (n ¼ 77)
Failed medical treatment 57 (80.2) 62 (80.5)
Recurrent hyperthyroidism after
medical treatment
12 (16.9) 4 (5.1)
Adverse effects of medical treatment 1 (1.4) 3 (3.8)
Patient’s choice 1 (1.4) 0 (0)
Thyroid volume responsible for
compressive symptoms
0 (0) 4 (5.1)
Severe ophthalmopathy 0 (0) 4 (5.1)
Abbreviations: MIT, minimal-incision thyroidectomy; CT, conventional thyroidectomy.





(n ¼ 77) p value
Incision length, mm 31.3 6 0.8 53.5 6 2.5 <.001
Mean operative time, min 61.6 6 4.6 65.8 6 4.8 NS
Mean glandular volume, mL 39.4 6 3.0 53.7 6 2.9 <.001
Estimated blood loss, mL 22.9 6 6.9 32.8 6 6.7 NS
Hospital stay, h 28.2 6 2.0 28.2 6 2.5 NS
Postoperative pain (VAS: 1–10)
6 h 4.3 6 0.6 8.3 6 0.4 <.05
18 h 1.2 6 0.4 3.2 6 0.4 <.05
Cosmetic satisfaction
(NSS: 1–10)
8.4 6 0.3 3.8 6 0.9 <.05
Incidental carcinoma, no. (%) 7 (9.8%) 4 (5.1%) NS
Abbreviations: MIT, minimal-incision thyroidectomy; CT, conventional thyroidectomy; VAS,
visual analogue scale; NSS, numerical score system; NS, not significant.
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analysis. The final length of skin incision was signifi-
cantly shorter in the minimal-incision thyroidectomy than
that in the conventional thyroidectomy group (31.3 6 0.8
vs 53.5 6 2.5 mm, p < .001). The mean glandular vol-
ume was significantly lower in the minimal-incision thy-
roidectomy than that in the conventional thyroidectomy
group, whereas there were no significant differences in
the estimated blood loss between the 2 groups. The
patient’s hospital stay did not significantly differ between
the 2 groups. Importantly, patients undergoing minimal-
incision thyroidectomy experienced significantly less
postoperative pain and were more satisfied with the cos-
metic result than patients who underwent conventional
thyroidectomy.
Pathologic examination of the surgical specimens
confirmed Graves’ disease in all patients and revealed
incidental papillary microcarcinoma in 7 patients (9.8%)
in the minimal-incision thyroidectomy and in 4
patients (5.1%) in the conventional thyroidectomy groups
(Table 2).
No statistically significant differences were observed
between the 2 groups with regard to postoperative com-
plications. In particular, asymptomatic hypocalcemia
occurred in 10 patients (14.0%), transient symptomatic
hypocalcemia in 8 patients (11.2%), permanent hypopara-
thyroidism in none, transient cord palsy in 4 patients
(5.6%), and permanent cord palsy in 2 patients (2.8%) in
the minimal-incision thyroidectomy group compared with
7 patients (9.0%), 5 patients (6.4%), 0 patients, 2 patients
(2.5%), and 2 patients (2.5%) in the conventional thyroid-
ectomy group, respectively (Table 3). Only 1 patient in
both groups had early postoperative bleeding, which
required reoperation (p ¼ NS) (Table 3).
DISCUSSION
Because medical and radioactive iodine treatment are
limited by long-lasting and unpredictable late results,
some authors have proposed surgery as the treatment of
choice for Graves’ disease.1–4 Two recent evidence-based
studies have better defined the prominent role of surgery
and its safety.5,6 Patients may especially benefit from
total thyroidectomy for the immediate relief of the hyper-
thyroidism, easy hormonal substitution, the absence of
risk of disease recurrence, frequent improvement in both
ophthalmopathy and humoral autoimmunity, and a com-
plete pathologic examination of the gland. Nevertheless,
medical and radioactive iodine treatments are still supe-
rior to surgery in terms of cosmetic results and incidence
of complications.
Surgery has recently improved due to the advent
of minimally invasive procedures. Several techniques
have been proposed that would allow minimal surgical
access to the thyroid gland. These include totally endo-
scopic thyroidectomy with CO2 insufflation into the neck
(with anterior cervical approach, breast approach, or
transaxillary approach),19–22 video-assisted thyroidectomy
(VAT),11,13,14,23 open nonendoscopic minimal-incision
thyroidectomy,15,16,18 and, more recently, robotic thyroid-
ectomy.24 Although minimally invasive surgery has been
used to treat several types of thyroid disorders, the
increased gland vascularity in toxic diffuse goiter was
first considered a relative contraindication to the mini-
mally invasive approach because of the potential technical
difficulty and thus the high incidence of complications in
the presence of bleeding. However, Berti and colleagues
in 2004,17 Maeda and colleagues in 2006,25 and, more
recently, Alesina and colleagues in 201126 have demon-
strated that VAT is feasible and safe for the treatment of
Graves’ disease, with results equivalent to those of con-
ventional open surgery. The minimal length of surgical
incision (1.5–3 cm) is a key advantage of VAT in com-
parison with conventional thyroidectomy but at the same
time is the main limitation of this type of surgery. Indeed,
only glands with volumes 25 mL have been treated by
Berti and colleagues,17 whereas a maximum glandular
volume of 30 mL was established by Alesina and col-
leagues26 for their VAT patients. This implies that only
9% of patients in Berti’s series and 31% of patients in
Alesina’s series could be given this technique.
We have previously shown that minimal-incision thy-
roidectomy, that is, an open thyroidectomy performed
through a 2.5- to 3.5-cm incision, is safe and effective in
treating various thyroid disorders, in particular multinodu-
lar goiter, with a gland volume <80 mL being the only
limiting factor.18 We have demonstrated that results of
this procedure in terms of cosmetic satisfaction and post-
operative pain were significantly better when compared
with conventional thyroidectomy and, interestingly, were
comparable with those obtained after VAT.18 In the pres-
ent study, we focused our analysis only on patients with
Graves’ disease to establish whether minimal-incision
thyroidectomy can be considered safe and feasible even
in the treatment of this surgically demanding thyreopathy
with the only limiting factor of a gland volume 50 mL.
Although we do not routinely use Lugol’s iodine solution
to reduce gland vascularity preoperatively, only 1 patient
(1.4%) in the minimal-incision thyroidectomy group
needed reoperation for major postoperative bleeding. Op-
erative times were similar between the 2 study groups,
thus demonstrating that minimal-incision thyroidectomy
does not require a long learning curve as usually occurs
for VAT.12 Importantly, the incidences of transient/per-
manent hypocalcemia and transient/permanent cord palsy
after minimal-incision thyroidectomy did not significantly
differ from those following conventional thyroidectomy,
being comparable with values reported by previously pub-
lished meta-analysis on total thyroidectomy.27,28 Even
asymptomatic hypocalcemia occurred with the same
TABLE 3. Postoperative complications.
No of patients (%)
Complication MIT (n ¼ 71) CT (n ¼ 77) p value
Transient asymptomatic
hypocalcemia
10 (14.0) 7 (9.0) NS
Transient symptomatic
hypocalcemia
8 (11.2) 5 (6.4) NS
Permanent hypoparathyroidism 0 (0) 0 (0) NS
Transient cord palsy 4 (5.6) 2 (2.5) NS
Permanent cord palsy 2 (2.8) 2 (2.5) NS
Bleeding 1 (1.4) 1 (1.2) NS
Abbreviations: MIT, minimal-incision thyroidectomy; CT, conventional thyroidectomy; NS, not
significant.
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frequency in the minimal-incision thyroidectomy and con-
ventional thyroidectomy patients. Although our patient
groups were not comparable in terms of thyroid volume,
these data clearly demonstrate that minimal-incision thy-
roidectomy can be performed successfully without any
increase in the incidence of postoperative complications
and patients can be discharged at the first postoperative
day as safely as patients who have undergone conven-
tional thyroidectomy.
We also show that minimal-incision thyroidectomy pro-
vides significant advantages with regard to postoperative
pain and patients’ cosmetic satisfaction when compared
with conventional thyroidectomy. Although the axillary
approach, either endoscopic or robotic, may offer the best
cosmetic results among all the minimally invasive proce-
dures proposed for thyroid surgery, it cannot be recom-
mended in patients with bilateral thyroid disorders such
as Graves’ disease. In addition, all the extracervical
approaches cannot be properly defined minimally inva-
sive because of the long operative times and the wide tis-
sue dissection required.22,24 Interestingly, we could adopt
minimal-incision thyroidectomy in 47.9% of our patients
with Graves’ disease, which is a higher proportion than
that reported by the above-cited authors for VAT.
Independently of the approach, minimally invasive or
conventional, total thyroidectomy is the preferred opera-
tion because the rate of persistent or recurrent disease has
been reported to be 7.9% after subtotal resection29 with-
out any advantage in terms of persistent nerve palsy and
hypothyroidism. Moreover, the 7.4% (11/148) overall rate
of incidental microcarcinomas in our patients represents
an additional argument in favor of total thyroidectomy as
treatment of Graves’ disease.
In conclusion, within the limitations of a nonrandom-
ized analysis, our results indicate that minimal-incision
thyroidectomy is a feasible and reliable option for the
surgical treatment of selected patients with Graves’ dis-
ease. In particular, minimal-incision thyroidectomy may
provide all the benefits of minimally invasive surgery
even to those patients who are not suitable for other mini-
mally invasive techniques such as VAT.
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